{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:19:31Z","timestamp":1787951971596,"version":"build-2784847793"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"UNIVERSITY OF MICHIGAN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacep.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:28:03Z","timestamp":1787862483000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation (META-AF)"],"prefix":"10.1016","author":[{"given":"Amrish","family":"Deshmukh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muazzum M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurba","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Turin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7880-9745","authenticated-orcid":false,"given":"Kelly","family":"Arps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ghannam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson J.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Cunnane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Ghanbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Latchamsetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krit","family":"Jongnarangsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Frank","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Chugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Morady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif A.","family":"Oral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Oral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacep.2026.07.008_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jacep.2026.07.008_bib2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.jacep.2026.07.008_bib3","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.jacep.2026.07.008_bib4","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1161\/CIRCULATIONAHA.107.716712","article-title":"Catheter ablation for atrial fibrillation in patients with obesity","volume":"117","author":"Cha","year":"2008","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jacep.2026.07.008_bib5","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.hrthm.2008.08.011","article-title":"Atrial fibrillation progression and management: a 5-year prospective follow-up study","volume":"5","author":"Pappone","year":"2008","journal-title":"Heart Rhythm"},{"issue":"18","key":"10.1016\/j.jacep.2026.07.008_bib6","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/eurheartj\/ehn324","article-title":"Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years","volume":"29","author":"Tsang","year":"2008","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jacep.2026.07.008_bib7","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/europace\/euv214","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"17","author":"Anselmino","year":"2015","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.jacep.2026.07.008_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.hrthm.2017.02.023","article-title":"Impact of obesity on atrial fibrillation ablation: patient characteristics, long-term outcomes, and complications","volume":"14","author":"Winkle","year":"2017","journal-title":"Heart Rhythm"},{"issue":"20","key":"10.1016\/j.jacep.2026.07.008_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012253","article-title":"Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European observational multicenter study","volume":"8","author":"Provid\u00eancia","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.jacep.2026.07.008_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacep.2016.06.002","article-title":"The impact of first procedure success rate on the economics of atrial fibrillation ablation","volume":"3","author":"Mansour","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"12","key":"10.1016\/j.jacep.2026.07.008_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25473","article-title":"Association between quality of life and procedural outcome after catheter ablation for atrial fibrillation: a secondary analysis of a randomized clinical trial","volume":"3","author":"Terricabras","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.jacep.2026.07.008_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/ehac692","article-title":"Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study","volume":"44","author":"Andrade","year":"2023","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jacep.2026.07.008_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.123.012697","article-title":"Prognostic impact of sinus rhythm in atrial fibrillation patients: separating rhythm outcomes from randomized strategy findings from the CABANA trial","volume":"17","author":"Bunch","year":"2024","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"16","key":"10.1016\/j.jacep.2026.07.008_bib14","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.jacep.2026.07.008_bib15","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.jacep.2026.07.008_bib16","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation","volume":"64","author":"Pathak","year":"2014","journal-title":"JACC"},{"issue":"4","key":"10.1016\/j.jacep.2026.07.008_bib17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2337\/dc11-1299","article-title":"Long-term safety, tolerability, and weight loss associated with metformin in the diabetes prevention program outcomes study","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jacep.2026.07.008_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.hroo.2024.04.003","article-title":"Antiarrhythmic effects of metformin","volume":"5","author":"Mascarenhas","year":"2024","journal-title":"Heart Rhythm O2"},{"issue":"10","key":"10.1016\/j.jacep.2026.07.008_bib19","article-title":"Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation","volume":"3","author":"Lal","year":"2022","journal-title":"CR Med"},{"issue":"1","key":"10.1016\/j.jacep.2026.07.008_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-018-0805-5","article-title":"Metformin restores electrophysiology of small conductance calcium-activated potassium channels in the atrium of GK diabetic rats","volume":"18","author":"Fu","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.jacep.2026.07.008_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-019-1059-7","article-title":"Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK\/PPAR-\u03b1\/VLCAD pathway","volume":"18","author":"Bai","year":"2019","journal-title":"Lipids Health Dis"},{"issue":"14","key":"10.1016\/j.jacep.2026.07.008_bib22","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.1111\/jcmm.15407","article-title":"Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability","volume":"24","author":"Li","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jacep.2026.07.008_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117759","article-title":"Metformin therapy confers cardioprotection against the remodeling of gap junction in tachycardia-induced atrial fibrillation dog model","volume":"254","author":"Li","year":"2020","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.jacep.2026.07.008_bib24","first-page":"1","article-title":"Metformin improves lipid metabolism and reverses the warburg effect in a canine model of chronic atrial fibrillation","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"10.1016\/j.jacep.2026.07.008_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12265-020-10069-6","article-title":"Activation of AMP-activated protein kinases prevents atrial fibrillation","volume":"14","author":"Ozcan","year":"2021","journal-title":"J Cardiovasc Trans Res"},{"key":"10.1016\/j.jacep.2026.07.008_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-014-0123-x","article-title":"Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"10.1016\/j.jacep.2026.07.008_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197245","article-title":"Antihyperglycemic drugs use and new-onset atrial fibrillation: a population-based nested case control study","volume":"13","author":"Liou","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jacep.2026.07.008_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.009115","article-title":"Metformin is associated with a lower risk of atrial fibrillation and ventricular arrhythmias compared with sulfonylureas","volume":"14","author":"Ostropolets","year":"2021","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"5","key":"10.1016\/j.jacep.2026.07.008_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00592-021-01841-4","article-title":"Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study","volume":"59","author":"Zhou","year":"2022","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jacep.2026.07.008_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110626","article-title":"Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in South Korea","volume":"198","author":"Kim","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.jacep.2026.07.008_bib31","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1067\/mhj.2002.122518","article-title":"Quality of life improves with treatment in the Canadian trial of atrial fibrillation","volume":"143","author":"Dorian","year":"2002","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.jacep.2026.07.008_bib32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/oby.2002.104","article-title":"Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity","volume":"10","author":"Iacobellis","year":"2002","journal-title":"Obes Res"},{"issue":"12","key":"10.1016\/j.jacep.2026.07.008_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004378","article-title":"Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation","volume":"9","author":"Wong","year":"2016","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"13","key":"10.1016\/j.jacep.2026.07.008_bib34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/eurheartj\/eht099","article-title":"Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines","volume":"36","author":"Venteclef","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacep.2026.07.008_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12967-018-1598-0","article-title":"YKL-40 is highly expressed in the epicardial adipose tissue of patients with atrial fibrillation and associated with atrial fibrosis","volume":"16","author":"Wang","year":"2018","journal-title":"J Transl Med"},{"issue":"25","key":"10.1016\/j.jacep.2026.07.008_bib36","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1161\/CIRCULATIONAHA.120.052009","article-title":"Extracellular vesicles from epicardial fat facilitate atrial fibrillation","volume":"143","author":"Shaihov-Teper","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacep.2026.07.008_bib37","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0008-6363(00)00139-5","article-title":"Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation","volume":"47","author":"Ausma","year":"2000","journal-title":"Cardiovasc Res"},{"issue":"1\u20132","key":"10.1016\/j.jacep.2026.07.008_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11010-005-3780-y","article-title":"Compartmentation of energy metabolism in atrial myocardium of patients undergoing cardiac surgery","volume":"270","author":"Seppet","year":"2005","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"10.1016\/j.jacep.2026.07.008_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jacc.2007.09.055","article-title":"Combined metabolomic and proteomic analysis of human atrial fibrillation","volume":"51","author":"Mayr","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.jacep.2026.07.008_bib40","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jacc.2013.03.061","article-title":"Mitochondrial dysfunction as an arrhythmogenic substrate","volume":"62","author":"Montaigne","year":"2013","journal-title":"JACC"},{"issue":"1","key":"10.1016\/j.jacep.2026.07.008_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/CIRCEP.114.001632","article-title":"Left atrial transcriptional changes associated with atrial fibrillation susceptibility and persistence","volume":"8","author":"Deshmukh","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"10.1016\/j.jacep.2026.07.008_bib42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.cardfail.2019.08.005","article-title":"Molecular mechanism of the association between atrial fibrillation and heart failure includes energy metabolic dysregulation due to mitochondrial dysfunction","volume":"25","author":"Ozcan","year":"2019","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacep.2026.07.008_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yjmcc.2017.12.012","article-title":"Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF","volume":"115","author":"Hohendanner","year":"2018","journal-title":"J Mol Cell Cardiol"},{"issue":"23","key":"10.1016\/j.jacep.2026.07.008_bib44","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jacc.2022.09.041","article-title":"Enhanced mitochondrial calcium uptake suppresses atrial fibrillation associated with metabolic syndrome","volume":"80","author":"Fossier","year":"2022","journal-title":"JACC"},{"issue":"1","key":"10.1016\/j.jacep.2026.07.008_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97449-3","article-title":"The mitochondrial calcium uniporter promotes arrhythmias caused by high-fat diet","volume":"11","author":"Joseph","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jacep.2026.07.008_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf081","article-title":"Mitochondrial damage mediates STING activation driving obesity-mediated atrial fibrillation","volume":"27","author":"Cao","year":"2025","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.jacep.2026.07.008_bib47","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.bbalip.2016.02.016","article-title":"Lipid metabolism and signaling in cardiac lipotoxicity","volume":"1861","author":"D\u2019Souza","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacep.2026.07.008_bib48","article-title":"Enhancing fatty acids oxidation via L-Carnitine attenuates obesity-related atrial fibrillation and structural remodeling by activating AMPK signaling and alleviating cardiac lipotoxicity","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.jacep.2026.07.008_bib49","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/europace\/euab122","article-title":"Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial","volume":"23","author":"Gessler","year":"2021","journal-title":"Europace"},{"issue":"12","key":"10.1016\/j.jacep.2026.07.008_bib50","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamacardio.2025.4007","article-title":"Aggressive risk factor Reduction Study for atrial fibrillation (ARREST-AF) implications for ablation outcomes: a randomized clinical trial","volume":"10","author":"Pathak","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacep.2026.07.008_bib51","article-title":"Improving outcomes of atrial fibrillation ablation by integrated personalized lifestyle interventions: a randomized controlled trial","volume":"30","author":"Vermeer","year":"2025","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.jacep.2026.07.008_bib52","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.jacc.2018.03.519","article-title":"Progression of device-detected subclinical atrial fibrillation and the risk of heart failure","volume":"71","author":"Wong","year":"2018","journal-title":"JACC"},{"issue":"12","key":"10.1016\/j.jacep.2026.07.008_bib53","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1016\/j.hrthm.2025.07.002","article-title":"Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: insights from the ARTESiA trial","volume":"22","author":"Boriani","year":"2025","journal-title":"Heart Rhythm"},{"issue":"25","key":"10.1016\/j.jacep.2026.07.008_bib54","first-page":"e727","article-title":"Randomized controlled trial of metformin and lifestyle\/risk factor modification for upstream prevention of atrial fibrillation progression: the targeting risk interventions and metformin for atrial fibrillation (TRIM-AF) trial","volume":"150","author":"Chung","year":"2024","journal-title":"Circulation"},{"issue":"9702","key":"10.1016\/j.jacep.2026.07.008_bib55","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study","volume":"374","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jacep.2026.07.008_bib56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","volume":"2","author":"Preiss","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.jacep.2026.07.008_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ejhf.2122","article-title":"A prospective STudy using invAsive haemodynamic measurements following catheter ablation for AF and early HFpEF: STALL AF-HFpEF","volume":"23","author":"Sugumar","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.jacep.2026.07.008_bib58","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/CIRCULATIONAHA.117.030093","article-title":"High prevalence of occult heart failure with preserved ejection fraction among patients with atrial fibrillation and dyspnea","volume":"137","author":"Reddy","year":"2018","journal-title":"Circulation"},{"issue":"41","key":"10.1016\/j.jacep.2026.07.008_bib59","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1093\/eurheartj\/ehz203","article-title":"A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial","volume":"40","author":"Mohan","year":"2019","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jacep.2026.07.008_bib60","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12020-021-02687-0","article-title":"Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial","volume":"72","author":"Ladeiras-Lopes","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.jacep.2026.07.008_bib61","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12872-022-02845-w","article-title":"Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials","volume":"22","author":"Kamel","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacep.2026.07.008_bib62","article-title":"Effect of metformin on epicardial adipose tissue in patients with coronary artery disease without diabetes: a cardiac MRI substudy of the MET-remodel trial","volume":"24","author":"Al-Talabany","year":"2021","journal-title":"Obes Med"},{"issue":"4","key":"10.1016\/j.jacep.2026.07.008_bib63","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/HYPERTENSIONAHA.113.02619","article-title":"Metformin protects against systolic overload\u2013induced heart failure independent of AMP-activated protein kinase \u03b12","volume":"63","author":"Xu","year":"2014","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.jacep.2026.07.008_bib64","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/FJC.0000000000001256","article-title":"Metformin protects against sunitinib-induced cardiotoxicity: investigating the role of AMPK","volume":"79","author":"Kuburas","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacep.2026.07.008_bib65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.trsl.2020.10.002","article-title":"Biphasic effect of metformin on human cardiac energetics","volume":"229","author":"Emelyanova","year":"2021","journal-title":"Transl Res"},{"key":"10.1016\/j.jacep.2026.07.008_bib66","article-title":"Metformin preconditioning protects against myocardial stunning and preserves protein translation in a mouse model of cardiac arrest","volume":"4","author":"Rutledge","year":"2023","journal-title":"J Mol Cell Cardiol Plus"},{"issue":"4","key":"10.1016\/j.jacep.2026.07.008_bib67","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCEP.112.972265","article-title":"AMP-activated protein kinase","volume":"5","author":"Harada","year":"2012","journal-title":"Circ Arrhythmia Electrophysiol"},{"issue":"1","key":"10.1016\/j.jacep.2026.07.008_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jacc.2015.04.056","article-title":"Atrial fibrillation activates AMP-dependent protein kinase and its regulation of cellular calcium handling: potential role in metabolic adaptation and prevention of progression","volume":"66","author":"Harada","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"51","key":"10.1016\/j.jacep.2026.07.008_bib69","doi-asserted-by":"crossref","first-page":"35839","DOI":"10.1074\/jbc.M109.057273","article-title":"Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction","volume":"284","author":"Ikeda","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jacep.2026.07.008_bib70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cvr\/cvv212","article-title":"LKB1 deletion causes early changes in atrial channel expression and electrophysiology prior to atrial fibrillation","volume":"108","author":"Kim","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10.1016\/j.jacep.2026.07.008_bib71","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/CIRCULATIONAHA.121.055373","article-title":"Atrial-specific LKB1 knockdown represents a novel mouse model of atrial cardiomyopathy with spontaneous atrial fibrillation","volume":"144","author":"Hulsurkar","year":"2021","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacep.2026.07.008_bib72","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-121-3-199408010-00008","article-title":"The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results","volume":"121","author":"Goodman","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jacep.2026.07.008_bib73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1198\/000313001300339897","article-title":"The abuse of power: the pervasive fallacy of power calculations for data analysis","volume":"55","author":"Hoenig","year":"2001","journal-title":"Am Statistician"},{"issue":"11","key":"10.1016\/j.jacep.2026.07.008_bib74","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.jacep.2025.07.011","article-title":"Atrial arrhythmia burden (SMURDEN) after ablation of AF is associated with improvement in quality of life","volume":"11","author":"Bidaoui","year":"2025","journal-title":"JACC Clin Electrophysiol"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26006717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26006717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:40:59Z","timestamp":1787949659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X26006717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":74,"alternative-id":["S2405500X26006717"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2026.07.008","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation (META-AF)","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}